SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Zim Laboratories - Quaterly Results

07 Aug 2025 Evaluate
The sales for the June 2025 quarter moved down to Rs. 714.28 millions as compared to Rs. 820.04 millions during the year-ago period.The Net Loss for the quarter ended June 2025 is Rs. -16.93 millions as compared to Net Profit of Rs. 7.59 millions of corresponding quarter ended June 2024The company reported a degrowth in operating Profit to 58.10 millions from 88.58 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 714.28 820.04 -12.90 714.28 820.04 -12.90 3756.36 3654.73 2.78
Other Income 14.76 9.80 50.61 14.76 9.80 50.61 56.21 46.91 19.83
PBIDT 58.10 88.58 -34.41 58.10 88.58 -34.41 488.90 447.94 9.14
Interest 33.04 28.58 15.61 33.04 28.58 15.61 113.86 69.24 64.44
PBDT 25.06 60.00 -58.23 25.06 60.00 -58.23 375.04 378.70 -0.97
Depreciation 47.90 49.16 -2.56 47.90 49.16 -2.56 198.91 148.29 34.14
PBT -22.84 10.84 -310.70 -22.84 10.84 -310.70 176.13 230.41 -23.56
TAX -5.91 3.25 -281.85 -5.91 3.25 -281.85 58.68 62.84 -6.62
Deferred Tax -5.91 1.15 -613.91 -5.91 1.15 -613.91 14.21 54.55 -73.95
PAT -16.93 7.59 -323.06 -16.93 7.59 -323.06 117.45 167.57 -29.91
Equity 487.26 487.26 0.00 487.26 487.26 0.00 487.26 487.26 0.00
PBIDTM(%) 8.13 10.80 -24.70 8.13 10.80 -24.70 13.02 12.26 6.19

Zim Laboratories Share Price

76.08 3.39 (4.66%)
15-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1696.65
Dr. Reddys Lab 1218.30
Cipla 1226.65
Zydus Lifesciences 936.00
Lupin 2339.20
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×